# Tiotropium/Salmeterol/Fluticasone Fixed Dose Combination Tratment Via Discair vs Tiotropium Via Handihaler + Salmeterol/Fluticasone Via Diskus Free Combination Treatment

> **NCT03395002** · PHASE4 · COMPLETED · sponsor: **Neutec Ar-Ge San ve Tic A.Ş** · enrollment: 58 (actual)

## Conditions studied

- COPD

## Interventions

- **DRUG:** Tiotropium/Salmeterol/Fluticasone 9/50/500 mcg Inhalation Powder
- **DRUG:** Tiotropium 18 mcg Inhalation Powder
- **DRUG:** Salmeterol/Fluticasone 50/500 mcg Inhalation Powder

## Key facts

- **NCT ID:** NCT03395002
- **Lead sponsor:** Neutec Ar-Ge San ve Tic A.Ş
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-22
- **Primary completion:** 2020-04-30
- **Final completion:** 2020-04-30
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2020-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03395002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03395002, "Tiotropium/Salmeterol/Fluticasone Fixed Dose Combination Tratment Via Discair vs Tiotropium Via Handihaler + Salmeterol/Fluticasone Via Diskus Free Combination Treatment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03395002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*